ARCHIVES

High Risk Youth Targeted In Concept Ok’d By Advisors

This article is from The Cancer Letter archive.

Vol. 17 No. 06 | February 8, 1991

Download PDF Visit The Full Archive

Related Articles

Mendelsohn Defends ImClone’s Actions And His Role In Development of C225

October 18, 2002

In Brief: NCI Study Finds No Relation Of Fluoridated Water To Cancer Incidence In U.S. Counties

December 5, 1975

Appropriators Project 1.2% Increase for NIH, Due to Budget Plan

June 20, 1997

NCI, DCT Board Cool Toward AMA, ACOS, VA Role In Clinical Trials

March 3, 1989

NCAB Working Group To Hold Open And Closed Sessions

January 20, 1995

Clinical Trials: For ER+ Breast Cancer, Post-Tamoxifen, NSABP Testing Aromasin In Large Trial

June 1, 2001